Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Epizyme + 20 Stocks Moving In Monday's Pre-Market Session

Author: Lisa Levin | June 27, 2022 06:31am

Gainers

  • Tenax Therapeutics, Inc. (NASDAQ:TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
  • Epizyme, Inc. (NASDAQ:EPZM) rose 57.2% to $1.50 in pre-market trading after Ipsen announced plans to acquire the company.
  • Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 49.2% to $0.5550 in pre-market trading after jumping 17% on Friday.
  • FedNat Holding Company (NASDAQ:FNHC) rose 30.4% to $0.3389 in pre-market trading after dipping over 20% on Friday. FedNat, last month, announced a $15 million investment by Hale Partnership in Monarch National Insurance Company.
  • InflaRx N.V. (NASDAQ:IFRX) shares rose 28% to $0.9995 in pre-market trading after tumbling around 34% on Friday.
  • Ebang International Holdings Inc. (NASDAQ:EBON) rose 18.7% to $0.4401 in pre-market trading. Ebang International announced the receipt of Nasdaq notification regarding minimum bid price deficiency.
  • Kiromic BioPharma, Inc. (NASDAQ:KRBP) rose 16.7% to $0.42 in pre-market trading after dropping more than 25% on Friday. Kiromic BioPharma recently announced a strategic pipeline shift to prioritize its allogeneic, non-engineered off-the-shelf product candidate, Deltacel/KB-GDT.
  • Reed's, Inc. (NASDAQ:REED) rose 14.4% to $0.1601 in pre-market trading after dropping more than 20% on Friday. Reed's, last month, posted a Q1 loss of $0.05 per share.
  • AppTech Payments Corp. (NASDAQ:APCX) rose 13.8% to $0.70 in pre-market trading after gaining around 15% on Friday.
  • Applied Genetic Technologies Corporation (NASDAQ:AGTC) shares rose 13.5% to $0.70 in pre-market trading following a 25% drop on Friday.
  • Minerva Neurosciences, Inc. (NASDAQ:NERV) rose 13.3% to $3.59 in pre-market trading after gaining more than 9% on Friday.
  • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 11.9% to $0.34 in pre-market trading following a 9% decline on Friday.
  • ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 10.3% to $2.98 in pre-market trading after jumping 55% on Friday. ToughBuilt Industries recently announced closing of $6 million public offering.
  • RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 9.8% to $0.90 in pre-market trading. RedHill Biopharma recently announced a cost reduction plan expected to generate operational cost savings of approximately $50 million over the next 18 months.
  • Sorrento Therapeutics, Inc. (NASDAQ:SRNE) rose 9.2% to $2.26 in pre-market trading. Sorrento Therapeutics named Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services and former Governor of Wisconsin, as Covid-19 special consultant to Sorrento’s Chairman and CEO Henry Ji.

Don’t forget to check out our premarket coverage here .

Losers

  • JE Cleantech Holdings Limited (NASDAQ:JCSE) fell 15% to $10.73 in pre-market trading after dropping more than 28% on Friday.
  • SIGA Technologies, Inc. (NASDAQ:SIGA) fell 12.6% to $11.40 in pre-market trading. SIGA Technologies recently announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat).
  • Vivakor, Inc. (NASDAQ:VIVK) fell 9.8% to $2.13 in pre-market trading. Vivakor recently announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
  • ShiftPixy, Inc. (NASDAQ:PIXY) fell 8.8% to $0.28 in pre-market trading after tumbling over 10% on Friday.
  • Sharecare, Inc. (NASDAQ:SHCR) shares fell 7.8% to $1.77 in pre-market trading. Sharecare, last month, reported better-than-expected Q1 EPS and sales results, issued Q2 and FY22 guidance and reported a $50 million buyback.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) fell 7% to $1.74 in pre-market trading. Tonix Pharmaceuticals recently reported pricing of $30 million private placement of convertible redeemable preferred stock.

Posted In: AGTC APCX AVCT EBON EPZM EVFM FNHC IFRX JCSE KRBP NERV PIXY RDHL REED SHCR SIGA SRNE TBLT TENX TNXP